1419100-97-2 Usage
Uses
Used in Organic Synthesis:
(S)-2,2-diMethyl-1-(3-Methylpiperazin-1-yl)propan-1-one is used as a building block in organic synthesis for the creation of various complex molecules. Its unique structure allows for the formation of a wide range of compounds with different properties and applications.
Used in Pharmaceutical Intermediates:
In the pharmaceutical industry, (S)-2,2-diMethyl-1-(3-Methylpiperazin-1-yl)propan-1-one serves as an intermediate in the synthesis of various drugs. Its chiral nature and functional groups make it a valuable component in the development of new medications with specific therapeutic effects.
Check Digit Verification of cas no
The CAS Registry Mumber 1419100-97-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,1,9,1,0 and 0 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1419100-97:
(9*1)+(8*4)+(7*1)+(6*9)+(5*1)+(4*0)+(3*0)+(2*9)+(1*7)=132
132 % 10 = 2
So 1419100-97-2 is a valid CAS Registry Number.
1419100-97-2Relevant academic research and scientific papers
PIPERAZINE DERIVATIVES AS ANTIVIRAL AGENTS WITH INCREASED THERAPEUTIC ACTIVITY
-
Page/Page column 21, (2017/09/15)
The present invention provides 2-phenylpiperazine derivatives having a benzofuran-2-yl group which contributes to increase the antiviral activity as well as, for some substituents, the CC50, giving more active and less cytotoxic compounds. Alth
New 4-Acyl-1-phenylaminocarbonyl-2-phenylpiperazine Derivatives as Potential Inhibitors of Adenovirus Infection. Synthesis, Biological Evaluation, and Structure-activity Relationships
Sánchez-Céspedes, Javier,Martínez-Aguado, Pablo,Vega-Holm, Margarita,Serna-Gallego, Ana,Candela, José Ignacio,Marrugal-Lorenzo, José Antonio,Pachón, Jerónimo,Iglesias-Guerra, Fernando,Vega-Pérez, José Manuel
, p. 5432 - 5448 (2016/07/06)
The search for human adenovirus (HAdV)-specific antiviral drugs for the treatment of HAdV infections in immunocompromised patients continues to be a challenging goal for medicinal chemistry. Here, we report the synthesis, biological evaluation, and struct
